Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 14/20 | 0.43 |
| ▸ | ACE | P12821 | 9/20 | 0.43 |
| ▸ | ECE1 | P42892 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL7569185 | 0.70 | MEN1 (0.57) | TP53L3MBTL1KDM4EMAPTHPGD | |
| SCHEMBL27423471 | 0.70 | MME (0.43) | MMEACEECE1 | |
| SCHEMBL4522521 | 0.68 | KCNQ3 (0.53) | HPGD | |
| SCHEMBL2858904 | 0.68 | MME (0.38) | MMEACETP53MAPT | |
| SCHEMBL12592455 | 0.68 | KCNQ3 (0.53) | HPGD | |
| SCHEMBL7352068 | 0.68 | KCNQ3 (0.53) | HPGD | |
| SCHEMBL7352063 | 0.68 | KCNQ3 (0.53) | HPGD | |
| SCHEMBL839092 | 0.68 | KCNQ3 (0.53) | HPGD | |
| SCHEMBL31289649 | 0.67 | DPP4 (0.47) | TP53L3MBTL1MAPT | |
| SCHEMBL31289648 | 0.67 | DPP4 (0.47) | TP53L3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024092256-A2 | PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2024-05-02 | — | — | WO | disclosed |